Clinical Trial Update: Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial updates for cetrorelix pamoate given intramuscularly in men with symptomatic benign prostatic hyperplasia, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Cetrorelix Pamoate (cetrorelix pamoate)

Snippet

Sponsor: AEterna Zentaris | Conditions: Benign Prostatic Hypertrophy | Phase 3 | Status: COMPLETED | Results posted: 2011-01-19